Reply To: HPTN 083 results and standard of prevention?

  • Daisy Ouya

    Member
    June 15, 2020 at 4:44 pm

    Should cabotegravir be licensed for PrEP in gay men and trans women right away on the basis of HPTN083 results, or wait until HPTN084 gives an answer for cis women? Can we learn something from the F/TAF experience (label for MSM and transwomen and post-marketing commitment to do a trial in cis women)?